BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11478761)

  • 1. Evaluation of efficacy and safety of iron polymaltose complex and folic acid (Mumfer) vs iron formulation (ferrous fumarate) in female patients with anaemia.
    Reddy PS; Adsul BB; Gandewar K; Korde KM; Desai A
    J Indian Med Assoc; 2001 Mar; 99(3):154-5. PubMed ID: 11478761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia.
    Adsul BB; Desai A; Gawde A; Baliga V
    J Indian Med Assoc; 2005 Jun; 103(6):338-42. PubMed ID: 16225161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
    Bopche AV; Dwivedi R; Mishra R; Patel GS
    Indian Pediatr; 2009 Oct; 46(10):883-5. PubMed ID: 19430060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
    Khalafallah A; Dennis A; Bates J; Bates G; Robertson IK; Smith L; Ball MJ; Seaton D; Brain T; Rasko JE
    J Intern Med; 2010 Sep; 268(3):286-95. PubMed ID: 20546462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience.
    Geisser P
    Arzneimittelforschung; 2007; 57(6A):439-52. PubMed ID: 17691594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron supplementation in pregnancy--does the preparation matter?
    Melamed N; Ben-Haroush A; Kaplan B; Yogev Y
    Arch Gynecol Obstet; 2007 Dec; 276(6):601-4. PubMed ID: 17541618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
    Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis.
    Toblli JE; Brignoli R
    Arzneimittelforschung; 2007; 57(6A):431-8. PubMed ID: 17691593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of efficacy and tolerance of iron polymaltose complex and ferrous sulphate for treatment of iron deficiency anemia in infants].
    Amaral D; Galimberti G; Cuesta S; Pinto J; Ferrario C; Graciela E
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(2):97-101. PubMed ID: 23286539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
    Jaber L; Rigler S; Taya A; Tebi F; Baloum M; Yaniv I; Haj Yehia M; Tamary H
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):585-8. PubMed ID: 20930652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
    Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
    Kulnigg S; Stoinov S; Simanenkov V; Dudar LV; Karnafel W; Garcia LC; Sambuelli AM; D'Haens G; Gasche C
    Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
    Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
    Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study.
    Ortiz R; Toblli JE; Romero JD; Monterrosa B; Frer C; Macagno E; Breymann C
    J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1347-52. PubMed ID: 21859366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy.
    Singh K; Fong YF; Kuperan P
    Eur J Haematol; 1998 Feb; 60(2):119-24. PubMed ID: 9508353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-effect of the administration of ferrous fumarate in aged persons with iron deficiency].
    Lares-Asseff I; Pérez MG; López MC; Romero L; Camacho GA; Toledo A; Guillé AJ; Trujillo F; Juárez H; Flores J
    Rev Gastroenterol Mex; 1999; 64(4):159-66. PubMed ID: 10851577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
    Jacobs P; Johnson G; Wood L
    J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
    Erichsen K; Ulvik RJ; Grimstad T; Berstad A; Berge RK; Hausken T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):831-8. PubMed ID: 16225492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of iron-deficiency anaemia with ferrous gluconate].
    Milchev N; Ivancheva Kh; Paskaleva V
    Akush Ginekol (Sofiia); 2004; 43 Suppl 3():45-8. PubMed ID: 15673030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.